# Alpha Biopharma

**Canonical:** https://apis.io/providers/alphabiopharma/  
**Website:** https://www.alphabiopharma.com/en/  
**APIs profiled:** 0

Alpha Biopharma is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with an additional office in Beijing. The company focuses on the clinical development and commercialization of global innovative drugs across oncology and immunotherapy, spanning medical affairs, clinical operations, regulatory affairs and commercialization. Its lead product is Zorifertinib (formerly AZD-3759, marketed as Zorifer), a next-generation EGFR TKI designed for EGFR mutation positive advanced NSCLC patients with central nervous system metastases, which received NMPA approval in November 2024 as the first EGFR-TKI indicated for lung cancer with brain metastases. Alpha Biopharma also partners with Wugen Inc. on universal off-the-shelf memory NK and CAR-T cell therapies. The company raised a Series A led by Qiming Venture Partners. Alpha Biopharma publishes a corporate marketing website only and operates no public API, developer portal, or software platform.

## Kin Score — 4.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 4.5).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Alphabiopharma Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biopharmaceutical, Pharmaceuticals, Oncology, Immunotherapy, Clinical Development, Life Sciences, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/alphabiopharma/). Scores are computed from the provider's own public artifacts under a published rubric.